JP2022511392A5 - - Google Patents

Info

Publication number
JP2022511392A5
JP2022511392A5 JP2021517784A JP2021517784A JP2022511392A5 JP 2022511392 A5 JP2022511392 A5 JP 2022511392A5 JP 2021517784 A JP2021517784 A JP 2021517784A JP 2021517784 A JP2021517784 A JP 2021517784A JP 2022511392 A5 JP2022511392 A5 JP 2022511392A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
oxo
methyl
oxopropoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021517784A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022511392A (ja
JP7437847B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/053990 external-priority patent/WO2020072442A1/en
Publication of JP2022511392A publication Critical patent/JP2022511392A/ja
Publication of JP2022511392A5 publication Critical patent/JP2022511392A5/ja
Application granted granted Critical
Publication of JP7437847B2 publication Critical patent/JP7437847B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021517784A 2018-10-01 2019-10-01 レレバクタムの誘導体およびその使用 Active JP7437847B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862739746P 2018-10-01 2018-10-01
US62/739,746 2018-10-01
PCT/US2019/053990 WO2020072442A1 (en) 2018-10-01 2019-10-01 Derivatives of relebactam and uses thereof

Publications (3)

Publication Number Publication Date
JP2022511392A JP2022511392A (ja) 2022-01-31
JP2022511392A5 true JP2022511392A5 (enExample) 2022-09-20
JP7437847B2 JP7437847B2 (ja) 2024-02-26

Family

ID=68242885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021517784A Active JP7437847B2 (ja) 2018-10-01 2019-10-01 レレバクタムの誘導体およびその使用

Country Status (6)

Country Link
US (1) US11180500B2 (enExample)
EP (1) EP3860999B9 (enExample)
JP (1) JP7437847B2 (enExample)
CA (1) CA3114618C (enExample)
ES (1) ES2991492T3 (enExample)
WO (1) WO2020072442A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119431373B (zh) * 2024-07-24 2025-08-08 科睿迪(南京)医药科技有限公司 一种β-内酰胺酶抑制剂及其用途

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3658849A (en) 1969-02-19 1972-04-25 Reynolds Tobacco Co R Treatment of 2-substituted aldehydes with lead dioxide
DE3045373A1 (de) 1980-12-02 1982-07-01 Henkel KGaA, 4000 Düsseldorf Verwendung von estern der 3-hydrody-2,2-dimethylpropionsaeure als riechstoffe, diese enthaltende riechstoffkompositionen und 3-hydroxy-2,2-dimethyl-propionsaeurepropylester
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
SK16382000A3 (sk) * 1998-05-01 2001-05-10 Kyoto Pharmaceutical Industries, Ltd. Karbapénové deriváty, ich vyžitie a ich medziproduktové zlúčeniny
FR2812635B1 (fr) 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
WO2002092606A1 (en) 2001-05-15 2002-11-21 Takeda Chemical Industries, Ltd. Fused imidazolidine derivatives, process for preparation of the same and use thereof
WO2009151392A1 (en) 2008-06-14 2009-12-17 Astrazeneca Ab Novel derivatives of 11-piperazin-l-yldibenzo [b,f] [1,4] thiazepine for treating at least one syndrome or condition associated with schizophrenia and other psychotic disorders
UY30244A1 (es) 2006-03-30 2007-11-30 Tanabe Seiyaku Co Un proceso para preparar derivados de tetrahidroquinolina
WO2009033079A1 (en) 2007-09-07 2009-03-12 Xenoport, Inc. Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
TW200924746A (en) 2007-09-07 2009-06-16 Xenoport Inc Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
US20090099253A1 (en) 2007-10-15 2009-04-16 Xenoport, Inc. Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of Use
JP5038509B2 (ja) 2008-01-18 2012-10-03 メルク・シャープ・エンド・ドーム・コーポレイション β−ラクタマーゼ阻害剤
GB0801401D0 (en) 2008-01-25 2008-03-05 Barry Callebaut Ag Composition
US8987468B2 (en) 2008-02-04 2015-03-24 The Translational Genomics Research Institute Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives
US8722686B2 (en) 2008-09-19 2014-05-13 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
WO2010065709A2 (en) 2008-12-03 2010-06-10 Amin Khan Hydroxamic acid derivatives, preparation and therapeutic uses thereof
WO2010126820A2 (en) * 2009-04-30 2010-11-04 Merck Sharp & Dohme Corp. Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
CA2777043C (en) 2009-10-14 2015-12-15 Schering Corporation Substituted piperidines that increase p53 activity and the uses thereof
RS59255B1 (sr) 2010-04-20 2019-10-31 Fujifilm Toyama Chemical Co Ltd Derivat hidroksaminske kiseline
WO2011150380A1 (en) 2010-05-28 2011-12-01 Xenoport, Inc. Methods of treatment of fragile x syndrome, down's syndrome, autism and related disorders
SI2657234T1 (sl) 2010-12-22 2017-06-30 Meiji Seika Pharma Co., Ltd. Derivat optično-aktivnega diazabiciklooktana in metoda za njegovo izdelavo
US8772490B2 (en) 2010-12-22 2014-07-08 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivatives and process for preparing the same
AR086590A1 (es) 2011-05-30 2014-01-08 Sumitomo Chemical Co Compuestos de ciclohexanona y herbicidas que los comprenden
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
CA2960949A1 (en) 2014-09-12 2016-03-17 Tatsuya Honda Novel pharmaceutical composition containing hydroxamic acid derivative or salt thereof
CN106794162A (zh) 2014-09-12 2017-05-31 富山化学工业株式会社 组合使用新的异羟肟酸衍生物和抗菌性物质的方法
WO2016116788A1 (en) 2015-01-24 2016-07-28 Wockhardt Limited Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
CA2984024A1 (en) 2015-09-16 2017-03-23 Xuanzhu Pharma Co., Ltd. .beta.-lactamase inhibitors and uses thereof
US20170165371A1 (en) 2017-02-22 2017-06-15 Joel Steven Goldberg Novel synthesis of potential ester prodrugs
US10085999B1 (en) 2017-05-10 2018-10-02 Arixa Pharmaceuticals, Inc. Beta-lactamase inhibitors and uses thereof
MX2020004071A (es) 2017-10-02 2020-07-28 Arixa Pharmaceuticals Inc Derivados de aztreonam y usos de los mismos.

Similar Documents

Publication Publication Date Title
JP2022545291A5 (enExample)
JP5677634B2 (ja) 1,6−ジアザビシクロ[3,2,1]オクタン−7−オン誘導体および細菌感染の処置におけるそれらの使用
JP2021534124A5 (enExample)
CA3008006C (en) Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
JP2002535323A5 (enExample)
RU2019135891A (ru) ИНГИБИТОРЫ β-ЛАКТАМАЗ И ИХ ПРИМЕНЕНИЕ
AU2017228870A1 (en) Bicyclic aryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
JP2020519684A5 (enExample)
JPH09512785A (ja) オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
AU2018345523A1 (en) Chromane monobactam compounds for the treatment of bacterial infections
JP2006507326A5 (enExample)
IL205501A (en) Preparation of preparations for the treatment of arthritis
JP2004525876A5 (enExample)
JP2024512793A5 (enExample)
JP2013515037A5 (enExample)
JP2018536678A (ja) セフェム系化合物、それらの生成および使用
JP2020528412A5 (enExample)
RU2015122032A (ru) Оксазолидинонсодержащие соединения, композиции и способы их использования
KR20170132301A (ko) 신규한 헤테로사이클릭 화합물들 및 세균성 감염의 예방 또는 치료에서 그들의 용도
CA2463544A1 (en) Cross-linked glycopeptide-cephalosporin antibiotics
RU2008115512A (ru) ИНГИБИТОРЫ МЕТАЛЛО-β-ЛАКТАМАЗЫ
JP2025513877A5 (enExample)
JPS59181280A (ja) ペネム化合物および該化合物を含有する医薬組成物
CN107400126A (zh) 新型噁唑烷酮类化合物及其制备方法和在医学上的应用
RU2276154C2 (ru) Производные карбапенема, применение их для изготовления фармацевтической композиции, фармацевтическая композиция на их основе и способ лечения и/или профилактики инфекционных заболеваний